Contracts › 75N93022F00001
75N93022F00001: Nonclinical Services for the Development of Interventional Agents for Infectious Diseases
Awarded to Southern Research Institute by National Institutes of Health (NIH).
$2.4Mobligated
$2.4Mpotential value
30 April 2027current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75N93022F00001 |
|---|---|
| Vehicle | 75N93018D00006 |
| Awardee | Southern Research Institute |
| Awarding agency | National Institutes of Health (NIH) |
| Awarding office | NATIONAL INSTITUTES OF HEALTH NIAID |
| NAICS | 541714 Research and Development in Biotechnology (Except Nanobiotechnology) |
| PSC | AN11 Health R&D Services; Health Care Services; Basic Research |
| Place of performance | AL |
| Offers received | 3 |
| Period of performance | 19 May 2022 to 30 April 2027 |
| Potential end | 30 April 2027 |
| Estimated recompete solicitation | ~Q4 2026 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 04 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541714 contracts · All expiring contracts · USASpending record